全文获取类型
收费全文 | 2147939篇 |
免费 | 148310篇 |
国内免费 | 3980篇 |
专业分类
耳鼻咽喉 | 31522篇 |
儿科学 | 68035篇 |
妇产科学 | 60454篇 |
基础医学 | 303246篇 |
口腔科学 | 62948篇 |
临床医学 | 188007篇 |
内科学 | 409832篇 |
皮肤病学 | 48781篇 |
神经病学 | 168392篇 |
特种医学 | 84360篇 |
外国民族医学 | 595篇 |
外科学 | 327471篇 |
综合类 | 48599篇 |
现状与发展 | 7篇 |
一般理论 | 677篇 |
预防医学 | 153282篇 |
眼科学 | 51403篇 |
药学 | 165713篇 |
10篇 | |
中国医学 | 5062篇 |
肿瘤学 | 121833篇 |
出版年
2018年 | 20754篇 |
2016年 | 18589篇 |
2015年 | 20733篇 |
2014年 | 28820篇 |
2013年 | 43168篇 |
2012年 | 57647篇 |
2011年 | 61088篇 |
2010年 | 36105篇 |
2009年 | 34423篇 |
2008年 | 57533篇 |
2007年 | 62334篇 |
2006年 | 63157篇 |
2005年 | 60595篇 |
2004年 | 58608篇 |
2003年 | 56427篇 |
2002年 | 55076篇 |
2001年 | 104528篇 |
2000年 | 107301篇 |
1999年 | 90268篇 |
1998年 | 24080篇 |
1997年 | 21644篇 |
1996年 | 21147篇 |
1995年 | 19880篇 |
1994年 | 18443篇 |
1993年 | 17348篇 |
1992年 | 69504篇 |
1991年 | 67150篇 |
1990年 | 65992篇 |
1989年 | 64054篇 |
1988年 | 59066篇 |
1987年 | 57927篇 |
1986年 | 55226篇 |
1985年 | 52340篇 |
1984年 | 38921篇 |
1983年 | 33063篇 |
1982年 | 19306篇 |
1981年 | 17405篇 |
1979年 | 36706篇 |
1978年 | 25788篇 |
1977年 | 22635篇 |
1976年 | 20326篇 |
1975年 | 23067篇 |
1974年 | 27248篇 |
1973年 | 26571篇 |
1972年 | 25292篇 |
1971年 | 23682篇 |
1970年 | 22196篇 |
1969年 | 21355篇 |
1968年 | 19700篇 |
1967年 | 17648篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
Deng H. Le W. - D. Hunter C. B. 《世界核心医学期刊文摘》2006,2(6):17-18
背景:Parkin基因(PRKN)突变可导致常染色体隐性遗传性早发帕金森病(EOPD)。目的:探讨EOPD白人家族PRKN突变的表现和基因型-表型关系。设计:对EOPD家族的3代20例成员进行基因分析,该家族有4例患者。应用直接基因组DNA测序、半定量聚合酶链反应、实时定量聚合酶链反应以及逆转录酶聚合酶链反应分析以确定PRKN突变。结果:4例早发患者(年龄30—38岁)被确定有PRKN复合杂合突变(T240M和EX5_6缺失),虽然PRKN的杂合T240M和纯合EX5_6缺失突变已有描述,但是据悉,本文为上述复合杂合突变的首次报道。患者的表型为典型常染色体隐性遗传性EOPD的表现,其特征是对左旋多巴治疗有效、相对缓慢的进展和运动障碍。所有杂合突变的基因携带者(T240M或EX5_6缺失)和1例56岁的复合杂合突变女性携带者(T240M和EX5_6缺失)无任何神经系统症状。结论:研究发现,PRKN基因复合杂合突变(T240M和EX5_6缺失)导致一个大的白人家族中4例成员发生常染色体隐性遗传性EOPD。另外1例成员具有相同的突变,比4例患者的平均发病年龄大10岁,并且无本病的临床表现。不完全的外显率对遗传咨询具有暗示作用,并且提示复杂的基因一环境交互作用在PRKN相关EOPD的发病机制中发挥作用。 相似文献
54.
Hasan Sunar Gülara Hüseyinova Suat Canbaz Umit Halici Enver Duran 《Blood coagulation & fibrinolysis》2003,14(8):703-706
Low molecular weight heparins are widely used in the prophylaxis and treatment of thrombotic disorders. The effect of low molecular weight heparins on coagulation was examined ultrastructurally in an animal model. A test and a control group was formed, each consisting of five rabbits. Nadroparine (225 Institute of Chaoy Unit/kg twice daily) was applied to the test group for 10 days. The control group received 1 ml saline solution subcutaneously. Blood and vascular tissue samples collected at the end of the 10th day were evaluated under a JEM 100 B electron microscope. Platelet degranulation and agglutination was observed in the control group. Fibrin materials were detected in the cytoplasms and surroundings of degranulated platelets. Erythrocyte accumulation was remarkable on the vascular endothelium with intact coagulation periods. In the test group, outer membranes of platelets, hyalomere, and granular structures in the granulomeres were detected to be nearly intact. There were rare erythrocytes in the large vascular lumens. The aggregation phase had occurred but no agglutination was detected. Nadroparine seems to preserve consistency of lipoprotein membranes of platelets and granular structures containing enzymes, which contribute to the coagulation mechanisms. 相似文献
55.
S. Spinty H. Rogozinski G. T. Lealman J. E. Wraith 《Journal of inherited metabolic disease》2003,25(8):697-698
Summary: A female patient with isovaleric acidaemia had a successful outcome from pregnancy. 相似文献
56.
Pulmonary hamartomas are usually an incidental finding and range in size from 1 cm to 8 cm in diameter in various series. We report a case of a massive pulmonary hamartoma (size 25.5 × 17.5 × 6.5 cm and weighing 1134 g) in a 61 year old male who presented with a short history of breathlessness. The tumour was arising from the medial border of the right lung and occupying most of the right chest extending in to the anterior mediastinum. The tumour was compressing the right lung and there was no evidence of infiltration into the surrounding structures. It was successfully treated by surgical resection and final histology was pulmonary hamartoma with predominantly adipose and leiomyomatous differentiation. 相似文献
57.
58.
Sebastian Bonner Thomas Matte Mitchell Rubin Joanne K Fagan Jennifer Ahern David Evans 《The Journal of asthma》2006,43(1):31-35
Although studies have documented underuse of controller medications and overuse of short-acting inhaled ss(2)-agonist among children with persistent asthma in disadvantaged communities, the persistence of oral ss(2)-agonist use in pediatric practice has not been studied since inhaled short-acting ss(2)-agonists became widespread. We describe medications used to treat asthma among children 3 to 5 years of age at 10 Head Start and other subsidized preschool centers in East and Central Harlem, New York City. We interviewed 149 parents/guardians of children who were identified as having probable asthma based on physician's diagnosis, persistent symptoms, hospitalization, and medication use. We classified 86 of the 149 children (58%) as having current persistent asthma. Only 15 of them (17%) were reported to have used controller medications at least 5 days/week in the last 4 weeks-only 2 of whom used inhaled corticosteroids. By contrast, 53 children (62%) used oral ss(2)-agonist in the last 4 weeks, often (72%) in conjunction with nebulized or inhaled short-acting ss(2)-agonist. Use of oral ss(2)-agonist was associated with more severe symptoms. This study documents the continued widespread use of oral ss(2)-agonist for treatment of children in a low-income community with high prevalence of asthma. 相似文献
59.
60.